The trial found that early administration of TXA (3 h from injury) resulted in a numerical 6% reduction in death in the whole group, which failed to reach statistical significance [ 112 ].
← all excerpts
Exploiting the Molecular Properties of Fibrinogen to Control Bleeding Following Vascular Injury.
1
—
—